Methode Electronics Inc (NYSE:MEI) is expected to pay $0.11 on Apr 26, 2019. (NYSE:MEI) shareholders before Apr 11, 2019 will receive the $0.11 dividend. Methode Electronics Inc’s current price of $30.02 translates into 0.37% yield. Methode Electronics Inc’s dividend has Apr 12, 2019 as record date. Mar 15, 2019 is the announcement. The stock increased 2.25% or $0.66 during the last trading session, reaching $30.02. About 261,735 shares traded. Methode Electronics, Inc. (NYSE:MEI) has declined 23.63% since March 22, 2018 and is downtrending. It has underperformed by 28.00% the S&P500. Some Historical MEI News: 12/03/2018 – METHODE ELECTRONICS INC MEI.N – RONALD TSOUMAS, CURRENTLY METHODE’S CONTROLLER AND TREASURER, HAS BEEN PROMOTED TO SUCCEED HRUDICKA; 15/03/2018 – Methode Electronics’ Board Approves Dividend; 12/03/2018 – METHODE ELECTRONICS, REPORTS CFO CHANGE; 29/03/2018 – Report: Exploring Fundamental Drivers Behind Anavex Life Sciences, Methode Electronics, Wesco Aircraft, Monotype Imaging, Tejon; 29/05/2018 – Trivedi Global, Inc. and Su-Mei Liu Announce the Research Results on the Impact of a Biofield Energy Treated Nutraceutical for; 24/05/2018 – Methode Electronics Closes Below 200-Day Average: Technicals; 12/03/2018 – METHODE SAYS RONALD TSOUMAS TO SUCCEED JOHN HRUDICKA AS CFO; 12/03/2018 – Methode Electronics CFO John Hrudicka Resigns; 29/05/2018 – Trivedi Global, Inc. and Su-Mei Liu Announce Research Results on the Impact of a Biofield Energy Treated Nutraceutical for Decr; 13/03/2018 – Methode Electronics Closes Above 200-Day Moving Average
Bridger Management Llc decreased Dexcom Inc (DXCM) stake by 85.86% reported in 2018Q4 SEC filing. Bridger Management Llc sold 342,772 shares as Dexcom Inc (DXCM)’s stock rose 13.47%. The Bridger Management Llc holds 56,457 shares with $6.76 million value, down from 399,229 last quarter. Dexcom Inc now has $12.80 billion valuation. The stock decreased 2.74% or $4 during the last trading session, reaching $142.16. About 1.88M shares traded or 46.14% up from the average. DexCom, Inc. (NASDAQ:DXCM) has risen 161.89% since March 22, 2018 and is uptrending. It has outperformed by 157.52% the S&P500. Some Historical DXCM News: 02/05/2018 – DEXCOM 1Q ADJ LOSS/SHR 32C, EST. LOSS/SHR 33C; 27/03/2018 – FDA OKS MARKETING OF DEXCOM G6 ICGM; 27/03/2018 – DEXCOM INC – EXPECTS TO LAUNCH DEXCOM G6 CGM SYSTEMLATER THIS YEAR; 27/03/2018 – FDA Authorizes Marketing Of The New Dexcom G6(R) CGM Eliminating Need For Fingerstick Blood Testing For People With Diabetes; 27/03/2018 – U.S. FDA SAYS AUTHORIZATION OF ICGM SYSTEM CLASSIFIES THIS NEW TYPE OF DEVICE IN CLASS Il & SUBJECTS IT TO CERTAIN CRITERIA CALLED SPECIAL CONTROLS; 08/03/2018 – WAVEFORM: PTAB UPHOLDS PATENTS CHALLENGED BY DEXCOM; 02/05/2018 – DEXCOM 1Q LOSS/SHR 28C, EST. LOSS/SHR 33C; 09/04/2018 – DexCom Forms Golden Cross: Technicals; 29/03/2018 – Alger Spectra Adds DexCom, Cuts CBS, Buys More Facebook; 27/03/2018 – FDA Authorizes Marketing of the New Dexcom G6® CGM Eliminating Need for Fingerstick Blood Testing for People with Diabetes
Among 2 analysts covering Methode Electronics (NYSE:MEI), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Methode Electronics had 6 analyst reports since October 1, 2018 according to SRatingsIntel. The stock has “Neutral” rating by Robert W. Baird on Monday, October 1. The stock of Methode Electronics, Inc. (NYSE:MEI) has “Buy” rating given on Friday, March 8 by FBR Capital. The firm earned “Outperform” rating on Tuesday, December 4 by Robert W. Baird.
Methode Electronics, Inc. designs, manufactures, and markets component and subsystem devices worldwide. The company has market cap of $1.11 billion. The firm operates through four divisions: Automotive, Interface, Power Products, and Other. It has a 10.67 P/E ratio. The Automotive segment offers electronic and electro-mechanical devices, and related products to automobile original equipment manufacturers directly or through their tiered suppliers.
More notable recent Methode Electronics, Inc. (NYSE:MEI) news were published by: Globenewswire.com which released: “Methode Electronics’ Board Approves Dividend NYSE:MEI – GlobeNewswire” on March 15, 2019, also Globenewswire.com with their article: “Methode Electronics to Announce Third-Quarter Fiscal 2019 Results on Thursday, March 7, 2019 – GlobeNewswire” published on February 21, 2019, Seekingalpha.com published: “Methode Electronics, Inc. (MEI) CEO Donald Duda on Q3 2019 Results – Earnings Call Transcript – Seeking Alpha” on March 07, 2019. More interesting news about Methode Electronics, Inc. (NYSE:MEI) were released by: Benzinga.com and their article: “Benzinga’s Top Upgrades, Downgrades For March 8, 2019 – Benzinga” published on March 08, 2019 as well as Benzinga.com‘s news article titled: “Earnings Scheduled For March 7, 2019 – Benzinga” with publication date: March 07, 2019.
Since September 24, 2018, it had 0 insider purchases, and 28 insider sales for $20.83 million activity. Balo Andrew K sold $715,664 worth of stock. SAYER KEVIN R sold $845,930 worth of stock. Murphy Patrick Michael sold $57,104 worth of stock or 400 shares. 1,736 shares were sold by DOUBLEDAY RICHARD, worth $210,664. Shares for $1.51 million were sold by KAHN BARBARA on Monday, January 14. 10,550 shares valued at $1.58M were sold by Abbey Donald on Friday, November 9. ACE HEATHER S sold $627,294 worth of DexCom, Inc. (NASDAQ:DXCM) on Friday, November 9.
Analysts await DexCom, Inc. (NASDAQ:DXCM) to report earnings on May, 1. They expect $-0.17 earnings per share, up 46.88% or $0.15 from last year’s $-0.32 per share. After $0.54 actual earnings per share reported by DexCom, Inc. for the previous quarter, Wall Street now forecasts -131.48% negative EPS growth.
Bridger Management Llc increased Heron Therapeutics Inc (NASDAQ:HRTX) stake by 192,245 shares to 2.48 million valued at $64.39 million in 2018Q4. It also upped Mgm Resorts International (NYSE:MGM) stake by 33,917 shares and now owns 1.99 million shares. Caesars Entmt Corp (NASDAQ:CZR) was raised too.
More notable recent DexCom, Inc. (NASDAQ:DXCM) news were published by: Benzinga.com which released: “Spruce Point: Dexcom (NASDAQ:DXCM) Could Fall 45-60% – Benzinga” on March 21, 2019, also Nasdaq.com with their article: “Here’s Why Investors Should Buy DexCom (DXCM) Stock Now – Nasdaq” published on February 26, 2019, Nasdaq.com published: “DexCom’s (DXCM) Q4 Earnings Beat, International Revenues Up – Nasdaq” on February 25, 2019. More interesting news about DexCom, Inc. (NASDAQ:DXCM) were released by: Nasdaq.com and their article: “DexCom (DXCM) Q4 Earnings and Revenues Top Estimates – Nasdaq” published on February 21, 2019 as well as Seekingalpha.com‘s news article titled: “DexCom Q4 2018 Earnings Preview – Seeking Alpha” with publication date: February 20, 2019.
Among 8 analysts covering DexCom (NASDAQ:DXCM), 4 have Buy rating, 0 Sell and 4 Hold. Therefore 50% are positive. DexCom had 12 analyst reports since October 11, 2018 according to SRatingsIntel. On Thursday, October 11 the stock rating was maintained by Morgan Stanley with “Equal-Weight”. The company was maintained on Wednesday, February 20 by Northland Capital. The firm has “Buy” rating given on Friday, February 22 by Piper Jaffray. Goldman Sachs upgraded DexCom, Inc. (NASDAQ:DXCM) on Friday, October 19 to “Neutral” rating. As per Tuesday, January 8, the company rating was maintained by UBS. The rating was maintained by Morgan Stanley on Monday, February 25 with “Equal-Weight”. As per Wednesday, January 2, the company rating was maintained by Morgan Stanley. The company was maintained on Friday, February 22 by Oppenheimer. On Friday, February 22 the stock rating was maintained by Cowen & Co with “Buy”. The company was maintained on Tuesday, October 23 by Raymond James.
Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.